Cabaletta Bio (CABA) Assets Average (2019 - 2025)

Cabaletta Bio's Assets Average history runs 7 years deep, the most recent figure standing at $177.4 million for Q4 2025.

• On a quarterly basis, Assets Average fell 8.89% year-over-year to $177.4 million in Q4 2025; TTM through Dec 2025 was $177.4 million, a 8.89% decrease from a year earlier, with the FY2025 full-year figure at $175.1 million, down 20.19% from the prior year.
• Assets Average slipped to $177.4 million in Q4 2025 per CABA's latest filing, from $207.1 million in the prior quarter.
• Across five years, Assets Average topped out at $247.1 million in Q1 2024 and bottomed at $96.8 million in Q3 2022.
• The 5-year median for Assets Average is $159.6 million (2023), against an average of $158.5 million.
• Across the five-year window, Assets Average jumped 124.17% in 2024 and slipped 29.13% in 2025, its largest moves.
• Year by year, Assets Average stood at $124.5 million in 2021, then retreated by 16.2% to $104.3 million in 2022, then jumped by 104.63% to $213.5 million in 2023, then fell by 8.78% to $194.7 million in 2024, then declined by 8.89% to $177.4 million in 2025.
• Per Business Quant, the three latest CABA Assets Average figures stand at $177.4 million (Q4 2025), $207.1 million (Q3 2025), and $194.8 million (Q2 2025).